HK Stock Market Move | SR MEDICAL (00108) rose over 9% in morning trading, doubling from its July low. Chunyu Doctor recently reached a strategic cooperation with Liz.

SR MEDICAL (00108) rose over 9% in morning trading, doubling from its July low of HK$1.42. As of press time, it was up 4.89% at HK$2.895, with a turnover of HK$5.5724 million. On the news front, on September 25, Chunyu Doctor, the core platform of SR MEDICAL under Guorui Group, signed a strategic cooperation agreement with Lizicar Group, an international high-end medical brand, at Meiser Hospital in the Hainan Boao Lecheng International Medical Tourism Pilot Zone. This cooperation is an important business practice for Chunyu Doctor in connecting the closed loop of full-lifecycle health management for users, and also a key move by Guorui Group to promote the deep integration of "digital healthcare + high-end wellness + high-end community scenarios." As the core vehicle of Guorui Group's key layout in digital healthcare, Chunyu Doctor relies on the platform's 700,000 public hospital physicians, nearly 200 million accumulated users, and AI smart healthcare technology capabilities to build a mature online health service matrix covering online consultation, AI health assessment, chronic disease management, and health record management. It is accelerating its upgrade from an online consultation platform to a full-lifecycle digital health service provider, continuously exploring innovative models that integrate digital healthcare with physical scenarios.